Published in JAMA on November 01, 2006
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med (2008) 2.68
Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation (2012) 2.56
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21
A systematic review of validated methods for identifying heart failure using administrative data. Pharmacoepidemiol Drug Saf (2012) 1.86
Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease. J Hypertens (2016) 1.61
Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect. Atherosclerosis (2011) 1.59
Hospital-level variation in use of cardiovascular testing for adults with incident heart failure: findings from the cardiovascular research network heart failure study. JACC Cardiovasc Imaging (2014) 1.45
Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev (2012) 1.15
Liver abnormalities in cardiac diseases and heart failure. Int J Angiol (2011) 1.13
Patients' perspectives on nonadherence to statin therapy: a focus-group study. Perm J (2010) 1.12
Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc (2013) 1.12
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr Pharm Des (2009) 1.09
CKD and the risk of incident cancer. J Am Soc Nephrol (2014) 1.08
Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care (2014) 1.01
Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors. Ther Adv Drug Saf (2014) 0.98
Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study. BMC Med (2011) 0.95
The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type. J Med Econ (2012) 0.95
Statin treatment for patients with heart failure. Nat Rev Cardiol (2010) 0.94
Elevated BP after AKI. J Am Soc Nephrol (2015) 0.93
Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med (2013) 0.93
Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc (2013) 0.93
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea. BMC Health Serv Res (2014) 0.91
Impact of adherence to statins on chronic heart failure in primary prevention. Br J Clin Pharmacol (2008) 0.91
Effect of atorvastatin in patients with chronic heart failure - insights from randomized clinical trials. Arch Med Sci (2010) 0.88
Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization. BMC Cardiovasc Disord (2012) 0.88
Statins in heart failure: do we need another trial? Vasc Health Risk Manag (2013) 0.88
Sympathoinhibitory effect of statins in chronic heart failure. Clin Auton Res (2009) 0.87
Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population. Circ Heart Fail (2013) 0.85
Statins in heart failure: the paradox between large randomized clinical trials and real life. Mayo Clin Proc (2012) 0.85
Incident atrial fibrillation and risk of death in adults with chronic kidney disease. J Am Heart Assoc (2014) 0.83
Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial. J Card Fail (2011) 0.83
Statin use and risk of basal cell carcinoma. J Am Acad Dermatol (2009) 0.82
The case for statin therapy in chronic heart failure. Clin Res Cardiol (2007) 0.81
Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]). Am J Cardiol (2013) 0.81
The complex relationship of race to outcomes in heart failure with preserved ejection fraction. Am J Med (2014) 0.80
Lipophilic versus hydrophilic statin therapy for heart failure: a protocol for an adjusted indirect comparison meta-analysis. Syst Rev (2013) 0.80
Gender differences in statin prescription rates, adequacy of dosing, and association of statin therapy with outcome after heart failure hospitalization: a retrospective analysis in a community setting. Eur J Clin Pharmacol (2015) 0.80
Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure. Circ Heart Fail (2013) 0.79
Potential autonomic nervous system effects of statins in heart failure. Heart Fail Clin (2008) 0.78
Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies. Ther Clin Risk Manag (2016) 0.78
Should a statin be prescribed to every patient with heart failure? Heart Fail Rev (2007) 0.76
Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease. J Card Fail (2013) 0.75
Effects of Statin Therapy on Clinical Outcomes of Survivors of Acute Myocardial Infarction with Severe Systolic Heart Failure. PLoS One (2015) 0.75
Use of Electronic Health Data to Estimate Heart Failure Events in a Population-Based Cohort with CKD. Clin J Am Soc Nephrol (2016) 0.75
Incremental prognostic information from kidney function in patients with new onset coronary heart disease. Am Heart J (2013) 0.75
Statin use and risks for death and hospitalization in chronic heart failure. JAMA (2007) 0.75
Statin use and risks for death and hospitalization in chronic heart failure. JAMA (2007) 0.75
Trends in Incidence of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN). Am J Med (2016) 0.75
Comparative Effects of Statin Therapy versus Renin-Angiotensin System Blocking Therapy in Patients with Ischemic Heart Failure Who Underwent Percutaneous Coronary Intervention. Chonnam Med J (2016) 0.75
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure. Korean Circ J (2017) 0.75
Statin Treatment and Clinical Outcomes of Heart Failure Among Africans: An Inverse Probability Treatment Weighted Analysis. J Am Heart Assoc (2017) 0.75
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA (2004) 5.25
Prescription drug use in pregnancy. Am J Obstet Gynecol (2004) 4.92
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation (2004) 4.87
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA (2008) 4.74
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest (2007) 4.47
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol (2005) 3.96
Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71
Health plan members' views about disclosure of medical errors. Ann Intern Med (2004) 3.69
Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med (2007) 3.34
Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation (2006) 3.31
Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med (2008) 3.06
Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab (2007) 3.05
Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med (2010) 2.51
The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med (2008) 2.46
Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ (2005) 2.43
Variation in nursing home antipsychotic prescribing rates. Arch Intern Med (2007) 2.30
Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med (2007) 2.27
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med (2003) 2.19
Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol (2013) 2.17
Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife--SWAN, the study of women's health across the nation. Am J Obstet Gynecol (2008) 2.15
A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf (2012) 2.11
Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc (2004) 2.08
The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes (2008) 2.03
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg (2009) 2.00
Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol (2008) 2.00
A critical review of methods to evaluate the impact of FDA regulatory actions. Pharmacoepidemiol Drug Saf (2013) 2.00
Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 1.96
Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort. Diabetes Care (2011) 1.93
Prescribers' responses to alerts during medication ordering in the long term care setting. J Am Med Inform Assoc (2006) 1.92
Comparison of review articles published in peer-reviewed and throwaway journals. JAMA (2002) 1.89
Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med (2004) 1.86
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes. Arch Intern Med (2010) 1.86
A systematic review of validated methods for identifying heart failure using administrative data. Pharmacoepidemiol Drug Saf (2012) 1.86
Validation of a surveillance case definition for arthritis. J Rheumatol (2005) 1.85
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ (2005) 1.84
FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf (2006) 1.83
Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS (2002) 1.79
Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. Bone (2012) 1.72
Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure. Circ Cardiovasc Qual Outcomes (2013) 1.71
Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer (2007) 1.71
Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old-old. Arch Intern Med (2002) 1.70
The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care (2005) 1.68
Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc (2004) 1.68
Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care (2004) 1.66
Atypical antipsychotics and parkinsonism. Arch Intern Med (2005) 1.66
Bone resorption and fracture across the menopausal transition: the Study of Women's Health Across the Nation. Menopause (2012) 1.66
The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS (2004) 1.64
Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus: A Prospective Cohort Study. Ann Intern Med (2015) 1.64
Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc (2004) 1.63
Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease. J Hypertens (2016) 1.61
Clinical application of a computerized system for physician order entry with clinical decision support to prevent adverse drug events in long-term care. CMAJ (2006) 1.59
A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med (2003) 1.58
Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med (2004) 1.57
Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med (2002) 1.54
A demonstration of the impact of response bias on the results of patient satisfaction surveys. Health Serv Res (2002) 1.52
Patterns and predictors of mammography utilization among breast cancer survivors. Cancer (2006) 1.52
Pain management in nursing home residents with cancer. J Am Geriatr Soc (2015) 1.49
Communicating with patients about medical errors: a review of the literature. Arch Intern Med (2004) 1.48
Challenges of estimating health service utilization for osteoarthritis patients on a population level. J Rheumatol (2002) 1.48
Can pay-for-performance take nursing home care to the next level? J Am Geriatr Soc (2008) 1.45
Chronic disease score as a predictor of hospitalization. Epidemiology (2002) 1.43
Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc (2011) 1.43
Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations? A Time-Series Analysis. Ann Intern Med (2015) 1.42
Computerized physician order entry with clinical decision support in the long-term care setting: insights from the Baycrest Centre for Geriatric Care. J Am Geriatr Soc (2005) 1.41
Trends in prehospital delay in patients with acute myocardial infarction (from the Worcester Heart Attack Study). Am J Cardiol (2008) 1.36
Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf (2007) 1.35
Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study. Arch Intern Med (2008) 1.32
Creating a research data network for cardiovascular disease: the CVRN. Expert Rev Cardiovasc Ther (2008) 1.32
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. J Oral Maxillofac Surg (2009) 1.28
Medical abbreviations: writing little and communicating less. Arch Dis Child (2008) 1.28
Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc (2007) 1.28
Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure. J Oral Maxillofac Surg (2010) 1.27
Gender and risk of adverse outcomes in heart failure. Am J Cardiol (2004) 1.26
Exclusion of older adults and women from recent trials of acute coronary syndromes. J Am Geriatr Soc (2011) 1.23
Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc (2005) 1.22
Disclosure of medical errors: what factors influence how patients respond? J Gen Intern Med (2006) 1.21
Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS (2002) 1.21
Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007. Med Care (2011) 1.21
Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab (2002) 1.20
Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol (2002) 1.19
Medicare beneficiaries and free prescription drug samples: a national survey. J Gen Intern Med (2008) 1.18
Study of Women, Infant Feeding, and Type 2 diabetes mellitus after GDM pregnancy (SWIFT), a prospective cohort study: methodology and design. BMC Public Health (2011) 1.18
Prevalence of ocular fundus pathology in patients with chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.17
Nurse-physician communication in the long-term care setting: perceived barriers and impact on patient safety. J Patient Saf (2009) 1.16
Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol (2012) 1.16
Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med (2008) 1.16
Physical performance and frailty in chronic kidney disease. Am J Nephrol (2013) 1.16
Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers. Clin Infect Dis (2006) 1.15
Computerized clinical decision support during medication ordering for long-term care residents with renal insufficiency. J Am Med Inform Assoc (2009) 1.14
Nursing home residents and enrollment in Medicare Part D. J Am Geriatr Soc (2009) 1.14
Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Am J Manag Care (2006) 1.14
Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis. J Clin Epidemiol (2005) 1.13
Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc (2013) 1.12
Pay-for-performance in nursing homes. Health Care Financ Rev (2009) 1.11
Medication errors in the homes of children with chronic conditions. Arch Dis Child (2011) 1.11
Do-not-resuscitate orders in patients hospitalized with acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med (2004) 1.10
Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program. Pharmacoepidemiol Drug Saf (2012) 1.10
Computerized physician order entry with clinical decision support in long-term care facilities: costs and benefits to stakeholders. J Am Geriatr Soc (2007) 1.10